Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 42

    1.

    Risk of Developing Cardiovascular Disease after Involved Node Radiotherapy versus Mantle Field for Hodgkin Lymphoma.

    Maraldo MV, Brodin NP, Vogelius IR, Aznar MC, Munck Af Rosenschöld P, Petersen PM, Specht L.

    Int J Radiat Oncol Biol Phys. 2012 Jan 21. [Epub ahead of print]

    PMID:
    22270170
    [PubMed - as supplied by publisher]
    2.

    Electron Irradiation of Conjunctival Lymphoma-Monte Carlo Simulation of the Minute Dose Distribution and Technique Optimization.

    Brualla L, Zaragoza FJ, Sempau J, Wittig A, Sauerwein W.

    Int J Radiat Oncol Biol Phys. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22245192
    [PubMed - as supplied by publisher]
    3.

    Response to "Role of FDG-PET in the definition and management of involved-field radiation therapy for pediatric Hodgkin's lymphoma."Int J Radiat Oncol Biol Phys (2011;80:324-332).

    Wang J, Shi M.

    Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):494; author reply 494. No abstract available.

    PMID:
    22182722
    [PubMed - indexed for MEDLINE]
    4.

    Randomized Clinical Trial to Assess the Efficacy of Radiotherapy in Primary Mediastinal Large B-Lymphoma.

    Avilés A, Neri N, Fernández R, Huerta-Guzmán J, Nambo MJ.

    Int J Radiat Oncol Biol Phys. 2011 Dec 13. [Epub ahead of print]

    PMID:
    22172907
    [PubMed - as supplied by publisher]
    5.

    Revisiting low-dose total skin electron beam therapy in mycosis fungoides.

    Harrison C, Young J, Navi D, Riaz N, Lingala B, Kim Y, Hoppe R.

    Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e651-7. Epub 2011 Apr 12.

    PMID:
    21489711
    [PubMed - indexed for MEDLINE]
    6.

    Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.

    Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT.

    Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):268-76. Epub 2011 Nov 11.

    PMID:
    22079733
    [PubMed - in process]
    7.

    Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study.

    Cai L, Stauder MC, Zhang YJ, Poortmans P, Li YX, Constantinou N, Thariat J, Kadish SP, Nguyen TD, Kirova YM, Ghadjar P, Weber DC, Bertran VT, Ozsahin M, Mirimanoff RO.

    Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):284-91. Epub 2011 Nov 11.

    PMID:
    22079728
    [PubMed - in process]
    8.

    Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.

    Fox AM, Dosoretz AP, Mauch PM, Chen YH, Fisher DC, LaCasce AS, Freedman AS, Silver B, Ng AK.

    Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):277-83. Epub 2011 Oct 20.

    PMID:
    22019238
    [PubMed - in process]
    9.

    Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.

    Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP.

    Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):260-7. Epub 2011 Oct 17.

    PMID:
    22014950
    [PubMed - in process]
    10.

    Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition.

    Metwally H, Courbon F, David I, Filleron T, Blouet A, Rives M, Izar F, Zerdoud S, Plat G, Vial J, Robert A, Laprie A.

    Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):793-9. Epub 2010 Jul 7.

    PMID:
    20615626
    [PubMed - indexed for MEDLINE]
    11.

    Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma.

    Paumier A, Ghalibafian M, Gilmore J, Beaudre A, Blanchard P, el Nemr M, Azoury F, al Hamokles H, Lefkopoulos D, Girinsky T.

    Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1522-7. Epub 2011 Jun 24.

    PMID:
    21705151
    [PubMed - indexed for MEDLINE]
    12.

    Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.

    Hashimoto N, Sasaki R, Nishimura H, Yoshida K, Miyawaki D, Nakayama M, Uehara K, Okamoto Y, Ejima Y, Azumi A, Matsui T, Sugimura K.

    Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1509-14. Epub 2011 Jun 12.

    PMID:
    21664061
    [PubMed - indexed for MEDLINE]
    13.

    Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.

    Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Simpson R, Tsang RW.

    Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e659-66. Epub 2011 Jun 2.

    PMID:
    21640514
    [PubMed - indexed for MEDLINE]
    14.

    Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients.

    Templin T, Paul S, Amundson SA, Young EF, Barker CA, Wolden SL, Smilenov LB.

    Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):549-57. Epub 2011 Mar 21.

    PMID:
    21420249
    [PubMed - indexed for MEDLINE]
    15.

    Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma.

    Sánchez-Nieto B, Goset KC, Caviedes I, Delgado IO, Córdova A.

    Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e257-64. Epub 2011 May 27.

    PMID:
    21621341
    [PubMed - indexed for MEDLINE]
    16.

    Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.

    Haberer S, Belin L, Le Scodan R, Kirova YM, Savignoni A, Stevens D, Moisson P, Decaudin D, Pierga JY, Reyal F, Campana F, Fourquet A, Bollet MA.

    Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e145-52. Epub 2011 May 24.

    PMID:
    21605948
    [PubMed - indexed for MEDLINE]
    17.

    Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy.

    Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K.

    Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1122-7. Epub 2011 May 11.

    PMID:
    21570217
    [PubMed - indexed for MEDLINE]
    18.

    Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.

    Paumier A, Ghalibafian M, Beaudre A, Ferreira I, Pichenot C, Messai T, Lessard NA, Lefkopoulos D, Girinsky T.

    Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):199-205.

    PMID:
    21481723
    [PubMed - indexed for MEDLINE]
    19.

    Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.

    Ferreri AJ, Verona C, Politi LS, Chiara A, Perna L, Villa E, Reni M.

    Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):169-75. Epub 2010 Jun 26.

    PMID:
    20584577
    [PubMed - indexed for MEDLINE]
    20.

    Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.

    Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R.

    Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1802-8. Epub 2011 Apr 20.

    PMID:
    21514076
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk